Evidence map›Paper›PMID 36216973›Full record

ArticleCell biochemistry and biophysics2022

Metaphase Cells Enrichment for Efficient Use in the Dicentric Chromosome Assay.

Max Platkov, Uzi Hadad, Ariela Burg, Inna Levitsky, Michael Zagatzki, Omer Damri, Aryeh Weiss, Yair Lauber, Shirly Amar, Lior Carmel and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biochemistry and biophysics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Max Platkov *Nuclear Research Center Negev, 84190, Beer-Sheba, Israel.
Uzi Hadad *Ilse Katz Institute for Nanoscale Science and Technology, Ben Gurion University, Beer Sheba, Israel.
Ariela BurgDepartment of Chemical Engineering, Sami Shamoon College of Engineering, 8410802, Beer-Sheva, Israel.
Inna LevitskyDepartment of Chemical Engineering, Sami Shamoon College of Engineering, 8410802, Beer-Sheva, Israel.
Michael ZagatzkiMedical Corps, Israeli Defense Forces, Tel HaShomer, Israel.
Omer DamriDepartment of Chemical Engineering, Sami Shamoon College of Engineering, 8410802, Beer-Sheva, Israel.
Aryeh WeissFaculty of Engineering Bar-Ilan University Ramat-Gan, 5290002, Ramat-Gan, Israel.
Yair LauberFaculty of Engineering Bar-Ilan University Ramat-Gan, 5290002, Ramat-Gan, Israel.
Shirly AmarGenetics Lab, Soroka Medical Center, Beer Sheba, Israel.
Lior CarmelDepartment of Biomedical Engineering, Ben Gurion University, Beer Sheva, Israel.
Raphael GonenNuclear Research Center Negev, 84190, Beer-Sheba, Israel. rgonenrgonen@gmail.com.
Ben-Gurion University of the Negev · ILSami Shamoon College of Engineering · ILBar-Ilan University · ILIsrael Defense Forces Medical Corps · ILSoroka Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dicentric chromosome assay (DCA), is considered the 'gold standard' for radiation biodosimetry. Yet, DCA, as currently implemented, may be impractical for emergency response applications, especially when time is of the essence, owing to its labor-intensive and time-consuming nature. The growth of a primary lymphocyte culture for 48 h in vitro is required for DCA, and manual scoring of dicentric chromosomes (DCs) requires an additional 24-48 h, resulting in an overall processing time of 72-96 h for dose estimation. In order to improve this timing. we introduce a protocol that will detect the metaphase cells in a population of cells, and then will harvest only those metaphase cells. Our metaphase enrichment approach is based on fixed human lymphocytes incubated with monoclonal, anti-phosphorylated H3 histone (ser 10). Antibodies against this histone have been shown to be specific for mitotic cells. Colcemid is used to arrest the mitotic cells in metaphase. Following that, a flow-cytometric sorting apparatus isolates the mitotic fraction from a large population of cells, in a few minutes. These mitotic cells are then spread onto a slide and treated with our C-Banding procedure [Gonen et al. 2022], to visualize the centromeres with DAPI. This reduces the chemical processing time to ~2 h. This reduces the time required for the DCA and makes it practical for a much wider set of applications, such as emergency response following exposure of a large population to ionizing radiation.

Indexed as

Chromosomes, HumanRadiometryChromosome AberrationsDemecolcineDose-Response Relationship, RadiationHistonesHumansLymphocytesMetaphaseDemecolcineHistonesDAPIDicentricsFlow cytometryMetaphase enrichment

Identifiers

PMID36216973
OpenAlexW4304140229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.